| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Neuraxis, Inc (NRXS) has 3 insiders with recent SEC Form 4 filings, including 3 buys and 1 sell. NRXS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 1.13M | $9.28M | - | |
| Dir | 35.9K | $294.7K | - | |
| Dir | 33.9K | $278.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 23, 2025 | Aharon Gil62 | Director | Buy | 286,138 | $3.52 | $1,007,205.76 | New | +110.1% | - | |
| Jul 1, 2025 | Hannasch Brian70 | 10% Owner | Buy | 355,556 | $2.25 | $800,001.00 | +45.8% | +30.7% | - | |
| Apr 21, 2025 | Hannasch Brian70 | 10% Owner | Buy | 18,065 | $1.73 | $31,250.64 | +2.4% | +52.1% | - | |
| Dec 28, 2023 | Hannasch Brian70 | 10% Owner | Sell | 76 | $2.61 | $198.36 | - | +31.0% | -4.7% |